Disease

Y YETNEWS                                        Oct. 27, 2014
Udi Etsion
An Israel icompany has developed and installed in Guinea special inflatable isolation tents to be used to house and isolate Ebola patients.

Special inflatable tent being used to fight Ebola

The inflatable tents have also been purchased for the treatment of Ebola patients by other countries on the continent, according to the Israeli company SYS Technologies, which specializes in the development of clean-air systems and mobile operating theaters. The company said the units can be constructed and shipped within two weels.

The units use a positive pressure technology to create an absolute clear and isolated environment and maintain the structure. The company has also developed an incubator-like stretcher for the safe transfer of patients to the isolation tents.

Read full article
http://www.ynetnews.com/articles/0,7340,L-4584736,00.html

In a study for the New England Journal of Medicine, a team of experts had traced the disease to the village in Guéckédou, in southeastern Guinea, by reviewing hospital documents and speaking to those involved.

 Read Complete  story

ASSOCIATED PRESS                                                                     Oct. 28, 2014
By RODNEY MUHUMUZA

KAMPALA, Uganda--Athorities are having trouble figuring out how many more people are getting Ebola in Liberia and Sierra Leone and where the hot spots are in those countries, harming efforts to get control of the raging, deadly outbreak, the U.N.'s top Ebola official in West Africa said Tuesday.

"The challenge is good information, because information helps tell us where the disease is, how it's spreading and where we need to target our resources," Anthony Banbury told The Associated Press by phone from the Ghanaian capital of Accra, where the U.N. Mission for Ebola Emergency Response, or UNMEER, is based.

Health experts say the key to stopping Ebola is breaking the chain of transmission by tracing and isolating those who have had contact with Ebola patients or victims. Health care workers can't do that if they don't know where new cases are emerging.

"And unfortunately, we don't have good data from a lot of areas. We don't know exactly what is happening," said Banbury, the chief of UNMEER.

ASSOCIATED PRESS                                 Oct. 28, 2014
  GENEVA-- The Swiss agency that regulates new drugs said Tuesday it has approved an application for a clinical trial with an experimental Ebola vaccine at the Lausanne University Hospital.

In this picture provided by the World Health Organization, a package of vials of the first shipment of the experimental vaccine VSE-EBOV is opened at the Geneva Cantonal hospital on Wednesday, Oct. 22, 2014. The World Health Organization (WHO) welcomes the donation by the government of Canada of 800 vials of an experimental candidate vaccine, VSV-EBOV, against Ebola virus disease. Clinical safety trials with this experimental Ebola vaccine have already begun in healthy human volunteers in Mali, the United Kingdom and the United States after showing very promising results in animal research. . (AP Photo/WHO/Mathilde Missioneiro) 

Swissmedic said the trial will be conducted among 120 volunteer participants with support from the U.N. World Health Organization. The experimental vaccine is to be initially administered on healthy volunteers who will be sent as medical staff to fight the Ebola epidemic in West Africa.